8FDA | pdb_00008fda


XPK: [(1~{R})-1-[(3~{S},5~{S},8~{R},9~{S},10~{S},13~{S},17~{R})-3-methanoyloxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,13,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]ethyl]-methylidyne-azanium

XPK is a Ligand Of Interest in 8FDA designated by the Author
Help


Best-fitted instance in this entry
Other instances in this entry
IdentifierRanking for goodness of fit Ranking for geometry Real space R factor Real space correlation coefficient RMSZ-bond-length RMSZ-bond-angleOutliers of bond length Outliers of bond angle Atomic clashesStereochemical errorsModel completenessAverage occupancy
8FDA_XPK_A_601 57% 2% 0.132 0.9085.23 1.55 16 410100%1
8FDA_XPK_C_601 51% 2% 0.145 0.95.23 1.87 16 1030100%1
8FDA_XPK_D_601 43% 1% 0.148 0.8725.32 1.85 15 1120100%1
8FDA_XPK_B_601 41% 2% 0.145 0.865.29 1.75 16 920100%1
8FDA_XPK_D_602 14% 1% 0.252 0.8195.22 2.1 15 1630100%0.83
8FDA_XPK_C_602 11% 1% 0.253 0.7855.3 2.07 17 1300100%0.82